Table 3 Statistical analysis of APO2.7 expression in HMCLs treated with BVDV
From: Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
Mean ± SD % of APO2.7 expression BVDV vs CNT | p value | ||
|---|---|---|---|
JJN3 | 48 h | 32.8 ± 6.1 vs. 13.02 ± 2.3 | 0.0009 |
72 h | 51.35 ± 6.8 vs. 17.4 ± 9.7 | 0.001 | |
OPM2 | 48 h | 12.6 ± 2.5 vs. 4.5 ± 0.6 | 0.0007 |
72 h | 39.7 ± 7.2 vs. 6.2 ± 1.8 | 0.0001 | |
MM1.S | 48 h | 16.4 ± 1 vs. 8.4 ± 1.5 | 0.0001 |
72 h | 23.4 ± 1.7 vs. 10.4 ± 1.5 | 0.00003 | |
NCI-H929 | 48 h | 30.5 ± 3.3 vs. 10.5 ± 0.5 | 0.00002 |
72 h | 85.3 ± 3 vs. 10.2 ± 0.35 | < 0.0001 |